Opportunity Information: Apply for RFA DA 24 005
The funding opportunity "Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Clinical Trials Optional)" (RFA-DA-24-005) is a National Institutes of Health (NIH) discretionary grant call focused on understanding how psychosocial stress biologically and cognitively shapes health outcomes for people living with HIV (PLWH), particularly when substance use disorders (SUDs) and psychiatric conditions overlap. The central idea is to move beyond documenting that stress is linked to poorer outcomes and instead identify the specific neurocognitive and neurobiological mechanisms that explain how stress increases risk, worsens severity, or complicates the course of SUDs and co-occurring psychiatric disorders in the context of HIV. Because it is an R01 mechanism, it is aimed at well-developed, hypothesis-driven projects that can generate mechanistic insight rather than purely descriptive associations.
Research supported under this announcement is expected to concentrate on mechanisms in the brain and nervous system that connect psychosocial stress to complex morbidity. In practical terms, that can include neurocognitive pathways (for example, stress-related changes in executive function, attention, learning, memory, reward processing, or decision-making) as well as broader neurobiological systems that may be disrupted by chronic or acute stress. While the notice text does not list specific required methods, mechanistic work in this space commonly draws on neuroscience-informed approaches such as neuroimaging, psychophysiology, neuroendocrine and immune signaling, computational or behavioral tasks that probe cognition and reward, and other measures that help explain "how" stress translates into vulnerability or harm. A key emphasis is the intersection of three domains: HIV, SUD, and psychiatric disorders, with psychosocial stress positioned as a driver that may influence initiation, relapse, treatment response, symptom burden, or functional outcomes.
The opportunity uses the NIH R01 grant mechanism and is labeled "Clinical Trials Optional," meaning applicants may propose studies that do or do not involve a clinical trial component, as long as the work aligns with the mechanistic aims described. The funding instrument type is a grant, and the activity category is listed under education and health. The CFDA number associated with the program is 93.279. The listed award ceiling is $500,000 (as provided in the source data), which sets an upper bound for the award amount under this announcement.
Eligibility is broad and includes many types of U.S. organizations and certain non-U.S. entities. Eligible applicants include state, county, and city/township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations other than federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other organizations as allowed by NIH policy. The notice also explicitly highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible federal agencies; U.S. territories or possessions; regional organizations; tribal governments other than federally recognized entities; and non-domestic (non-U.S.) entities (foreign organizations). This breadth signals an intent to encourage applications from diverse institutional settings, including those serving populations disproportionately affected by HIV, substance use, and stress-related psychiatric burden.
Key administrative details from the posting include an original closing date of February 15, 2024, and a creation date of September 26, 2023. The sponsoring agency is the National Institutes of Health. Overall, the opportunity is designed for research teams that can integrate HIV-related clinical or population context with rigorous mechanistic neuroscience and neurocognitive science to clarify how psychosocial stress contributes to intertwined substance use and mental health outcomes among PLWH, and to generate knowledge that could ultimately inform better prevention and intervention strategies.Apply for RFA DA 24 005
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Clinical Trials Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2023-09-26.
- Applicants must submit their applications by 2024-02-15. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: FY24 IIJA/IRA Bureau of Land Management Oregon/Washington (ORWA) Youth Conservation Corps
Previous opportunity: Rural Surface Transportation Grant Progam
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 24 005
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 24 005) also looked into and applied for these:
| Funding Opportunity |
|---|
| Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Basic Experimental Studies with Humans (BESH) Required) Apply for RFA DA 24 006 Funding Number: RFA DA 24 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional) Apply for RFA DA 24 031 Funding Number: RFA DA 24 031 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) Apply for RFA DA 25 048 Funding Number: RFA DA 25 048 Agency: National Institutes of Health Category: Education, Health Funding Amount: $295,924 |
| Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) Apply for RFA DA 25 047 Funding Number: RFA DA 25 047 Agency: National Institutes of Health Category: Education, Health Funding Amount: $295,924 |
| Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional) Apply for RFA DA 24 033 Funding Number: RFA DA 24 033 Agency: National Institutes of Health Category: Education, Health Funding Amount: $600,000 |
| Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Basic Experimental Studies with Humans Required) Apply for RFA DA 24 032 Funding Number: RFA DA 24 032 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) Apply for PAR 23 276 Funding Number: PAR 23 276 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed) Apply for PAR 23 222 Funding Number: PAR 23 222 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Pre-Cancer Atlas (PCA) Research Centers (U01 Clinical Trial Not Allowed) Apply for RFA CA 23 040 Funding Number: RFA CA 23 040 Agency: National Institutes of Health Category: Education, Health Funding Amount: $800,000 |
| Single Source: Human Tumor Atlas Network Data Coordinating Center (HTAN-DCC; U24 Clinical Trial Not Allowed) Apply for RFA CA 23 041 Funding Number: RFA CA 23 041 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,800,000 |
| Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional) Apply for RFA DA 25 059 Funding Number: RFA DA 25 059 Agency: National Institutes of Health Category: Education, Health Funding Amount: $459,000 |
| Human Tumor Atlas (HTA) Research Centers (U01 Clinical Trial Not Allowed) Apply for RFA CA 23 039 Funding Number: RFA CA 23 039 Agency: National Institutes of Health Category: Education, Health Funding Amount: $800,000 |
| Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R01 Clinical Trial Not Allowed) Apply for RFA DA 25 011 Funding Number: RFA DA 25 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: $700,000 |
| Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional) Apply for PAR 23 308 Funding Number: PAR 23 308 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,700,000 |
| Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) Apply for PAR 24 047 Funding Number: PAR 24 047 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) Apply for PAR 23 304 Funding Number: PAR 23 304 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed) Apply for PAR 23 303 Funding Number: PAR 23 303 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional) Apply for RFA CA 24 006 Funding Number: RFA CA 24 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Applying Imaging Pipelines for Spatial Characterization of Cellular Interactions in HIV-related CNS Pathology and/or Substance Use (R61/R33 Clinical Trial Not Allowed) Apply for RFA DA 24 030 Funding Number: RFA DA 24 030 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed) Apply for RFA DA 25 012 Funding Number: RFA DA 25 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 24 005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
